Healthcare Mergers, Acquisitions & Ventures Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions & Ventures Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Biomet, Inc.
Biomet Announces Acquisition of the Assets of Cartilage Repair Company Cartilix
November 7th, 2009
Biomet, Inc., a global leader in the manufacture of orthopedic and dental medical devices, announced its acquisition of the assets of Cartilix, a Foster City, CA based company that has developed proprietary cartilage repair technology. Cartilix was founded in 2004 to develop cartilage repair and regeneration solutions. The company developed ChonDux™, a proprietary cartilage regeneration technology for repair of knee cartilage. ChonDux™ technology uses a biological adhesive and hydrogel to fill articular cartilage lesions. ChonDux™ technology is not yet commercially available. Clinical trials are scheduled to begin in Europe during...
Source: Healthcare Mergers, Acquisitions & Ventures Week (2009-11-07)
|
